Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | BRIP1 |
| Variant | E357* |
| Impact List | nonsense |
| Protein Effect | loss of function - predicted |
| Gene Variant Descriptions | BRIP1 E357* results in a premature truncation of the Brip1 protein at amino acid 357 of 1249 (UniProt.org). E357* confers resistance to interstrand crosslinking agents in BRIP1-null cells in culture (PMID: 33619228), however, due to the effects of other truncation mutations downstream of E357 (PMID: 18628483), is predicted to lead to a loss of Brip1 protein function. |
| Associated Drug Resistance | |
| Category Variants Paths |
BRIP1 mutant BRIP1 inact mut BRIP1 E357* |
| Transcript | NM_032043.3 |
| gDNA | chr17:g.61801324C>A |
| cDNA | c.1069G>T |
| Protein | p.E357* |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| XM_011525334.3 | chr17:g.61801324C>A | c.1069G>T | p.E357* | RefSeq | GRCh38/hg38 |
| XM_047436904.1 | chr17:g.61801324C>A | c.1069G>T | p.E357* | RefSeq | GRCh38/hg38 |
| XM_047436902.1 | chr17:g.61801324C>A | c.1069G>T | p.E357* | RefSeq | GRCh38/hg38 |
| XM_011525336.3 | chr17:g.61801324C>A | c.1069G>T | p.E357* | RefSeq | GRCh38/hg38 |
| XM_047436894.1 | chr17:g.61801324C>A | c.1069G>T | p.E357* | RefSeq | GRCh38/hg38 |
| XM_047436892.1 | chr17:g.61801324C>A | c.1069G>T | p.E357* | RefSeq | GRCh38/hg38 |
| NM_032043.3 | chr17:g.61801324C>A | c.1069G>T | p.E357* | RefSeq | GRCh38/hg38 |
| XM_047436900.1 | chr17:g.61801324C>A | c.1069G>T | p.E357* | RefSeq | GRCh38/hg38 |
| XM_047436901.1 | chr17:g.61801324C>A | c.1069G>T | p.E357* | RefSeq | GRCh38/hg38 |
| XM_047436895.1 | chr17:g.61801324C>A | c.1069G>T | p.E357* | RefSeq | GRCh38/hg38 |
| XM_047436897.1 | chr17:g.61801324C>A | c.1069G>T | p.E357* | RefSeq | GRCh38/hg38 |
| XM_047436903.1 | chr17:g.61801324C>A | c.1069G>T | p.E357* | RefSeq | GRCh38/hg38 |
| XM_011525341.4 | chr17:g.61801324C>A | c.1069G>T | p.E357* | RefSeq | GRCh38/hg38 |
| XM_047436893.1 | chr17:g.61801324C>A | c.1069G>T | p.E357* | RefSeq | GRCh38/hg38 |
| XM_047436891.1 | chr17:g.61801324C>A | c.1069G>T | p.E357* | RefSeq | GRCh38/hg38 |
| XM_047436896.1 | chr17:g.61801324C>A | c.1069G>T | p.E357* | RefSeq | GRCh38/hg38 |
| XM_011525333.4 | chr17:g.61801324C>A | c.1069G>T | p.E357* | RefSeq | GRCh38/hg38 |
| XM_011525335.4 | chr17:g.61801324C>A | c.1069G>T | p.E357* | RefSeq | GRCh38/hg38 |
| XM_011525332.4 | chr17:g.61801324C>A | c.1069G>T | p.E357* | RefSeq | GRCh38/hg38 |
| XM_011525340.4 | chr17:g.61801324C>A | c.1069G>T | p.E357* | RefSeq | GRCh38/hg38 |
| XM_047436899.1 | chr17:g.61801324C>A | c.1069G>T | p.E357* | RefSeq | GRCh38/hg38 |
| XM_011525339.4 | chr17:g.61801324C>A | c.1069G>T | p.E357* | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| BRIP1 E357* | Advanced Solid Tumor | resistant | Cisplatin | Preclinical - Cell culture | Actionable | In a preclinical study, Platinol (cisplatin) treatment did not inhibit viability of a cell line expressing BRIP1 E357* in culture (PMID: 33619228). | 33619228 |